Benzinga · Aug 31, 2026
Needham Reiterates Buy on Phreesia, Maintains $14 Price Target
Needham analyst Ryan MacDonald reiterates Phreesia (NYSE:PHR) with a Buy and maintains $14 price target.
PH
NYSE · PHR
Phreesia, Inc.
Healthcare · Medical - Healthcare Information Services
$10.94
Down-$0.16 (-1.44%)
Updated Sep 8, 2026, 8:43 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 961.63M
- P/E ratio
- -177.58
- Dividend yield
- 0.00%
- 52-week range
- $7.77 – $30.43
- Volume
- 807.9K
- Avg. volume
- 922.11K
Price performance
PHR price history
1M range · 20 trading sessions · Daily adjusted prices
PHR closed at $10.94 after 20 trading sessions, down 12.06% for the selected period.
- Last close
- $10.94
- Period change
- -12.06%
- Period low
- $10.94
- Period high
- $12.62
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $11.08 | $11.145 | $10.7203 | $10.94 | 807.9K |
| Sep 3, 2026 | $11.02 | $11.42 | $10.78 | $11.10 | 1.26M |
| Sep 2, 2026 | $11.79 | $12.185 | $11.78 | $11.85 | 759.14K |
| Sep 1, 2026 | $11.99 | $12.22 | $11.77 | $11.84 | 506.26K |
| Aug 31, 2026 | $11.97 | $12.23 | $11.865 | $12.21 | 613.37K |
| Aug 28, 2026 | $11.80 | $12.29 | $11.80 | $12.15 | 508.62K |
| Aug 27, 2026 | $11.77 | $12.02 | $11.645 | $11.86 | 644.92K |
| Aug 26, 2026 | $11.37 | $11.72 | $11.37 | $11.60 | 585.3K |
| Aug 25, 2026 | $11.64 | $11.715 | $11.405 | $11.52 | 664.67K |
| Aug 24, 2026 | $12.03 | $12.10 | $11.685 | $11.69 | 626.52K |
| Aug 21, 2026 | $12.02 | $12.25 | $11.86 | $12.12 | 919.79K |
| Aug 20, 2026 | $11.89 | $12.09 | $11.70 | $12.00 | 862.12K |
| Aug 19, 2026 | $11.57 | $12.15 | $11.26 | $11.96 | 1.45M |
| Aug 18, 2026 | $11.72 | $11.8075 | $11.35 | $11.44 | 1.61M |
| Aug 17, 2026 | $12.00 | $12.285 | $11.37 | $11.58 | 1.09M |
| Aug 14, 2026 | $12.69 | $12.69 | $12.26 | $12.28 | 436.67K |
| Aug 13, 2026 | $12.34 | $12.67 | $12.22 | $12.62 | 491.56K |
| Aug 12, 2026 | $12.11 | $12.27 | $11.91 | $12.26 | 450.62K |
| Aug 11, 2026 | $12.29 | $12.645 | $12.19 | $12.27 | 747.76K |
| Aug 10, 2026 | $12.35 | $12.52 | $12.23 | $12.44 | 543.53K |
Latest PHR news
The latest Smart Investors Daily articles mentioning PHR.
Stock researchCompany · Overview
PHR research
Overview
Company profile and research snapshot.
Company profile
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $30.56
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 4, 2026 | Baird | Neutral | — |
| Sep 4, 2026 | DA Davidson | Buy | — |
| Sep 3, 2026 | Freedom Capital Markets | Buy | — |
| Sep 3, 2026 | RBC Capital | Outperform | — |
| Sep 3, 2026 | Wells Fargo | Equal-Weight | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 6, 2026
Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.
Yahoo · Aug 6, 2026
Enovis (ENOV) Beats Q2 Earnings and Revenue Estimates
Enovis (ENOV) delivered earnings and revenue surprises of +8.43% and +0.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Aug 6, 2026
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates
Schrodinger (SDGR) delivered earnings and revenue surprises of +113.33% and +15.58%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
